Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Neurovascular Research
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Aims

We evaluated endogenous melatonin levels in the acute phase of cerebral infarction and explored the impact of possible changes in melatonin levels on the prognosis of patients.

Methods

This study recruited acute ischemic stroke (AIS) patients from the Department of the Second Affiliated Hospital of Soochow University between December 2019 and June 2021, along with healthy control subjects. Salivary melatonin samples were collected from each participant between 7 pm and 10 pm, and fasting plasma was collected the following morning to measure the levels of inflammatory markers. The prognosis was assessed through follow-up three months after discharge. The relationship between melatonin levels and plasma inflammatory markers was assessed, followed by an analysis of the effect of melatonin levels on patient prognosis.

Results

The study enrolled a total of 160 participants, including 120 AIS patients aged 50 years or older (61.7% male) and 40 age-matched controls (55.0% male). The AIS group exhibited lower salivary melatonin levels at 19 ( = 0.002), 20 ( < 0.001), 21 ( < 0.001), and 22 ( < 0.001) o’clock, and the average melatonin level was also lower ( < 0.001). Logistic regression analysis models indicated an association between low melatonin levels and poor prognosis. Salivary melatonin levels demonstrated good predictive ability for the prognosis of AIS patients.

Conclusion

Melatonin levels were lower in AIS patients compared to controls. In addition, lower melatonin levels were associated with a poorer prognosis among AIS patients.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026302380240307091232
2024-03-08
2025-01-24

  • From This Site

    /content/journals/cnr/10.2174/0115672026302380240307091232
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CollaboratorsG.B.D.N. Global, regional, and national burden of neurological disorders, 1990- 2016: A systematic analysis for the global burden of disease study.Lancet Neurol.201618545948010.1016/s1474‑4422(18)30499‑x
     [Google Scholar]
  2. AllenC.L. BayraktutanU. Oxidative stress and its role in the pathogenesis of ischaemic stroke.Int. J. Stroke20094646147010.1111/j.1747‑4949.2009.00387.x
     [Google Scholar]
  3. YuanK. JinX. MoX. Novel diagnostic biomarkers of oxidative stress, ferroptosis, immune infiltration characteristics and experimental validation in ischemic stroke.Aging202416174676110.18632/aging.205415 38198162
     [Google Scholar]
  4. SaccoS. HarriottA.M. AyataC. Microembolism and other links between migraine and stroke.Neurology20231001571672610.1212/WNL.0000000000201699 36522158
     [Google Scholar]
  5. LiuC. WangG. HanW. TianQ. LiM. Ferroptosis: A potential therapeutic target for stroke.Neural Regen. Res.202419598899710.4103/1673‑5374.385284 37862200
     [Google Scholar]
  6. SkeneD.J. ArendtJ. Human circadian rhythms: Physiological and therapeutic relevance of light and melatonin.Ann. Clin. Biochem.200643534435310.1258/000456306778520142 17022876
     [Google Scholar]
  7. ArendtJ. BojkowskiC. FolkardS. Some effects of melatonin and the control of its secretion in humans.Ciba Found. Symp.198511726628310.1002/9780470720981.ch16 3836818
     [Google Scholar]
  8. AtanassovaP.A. TerzievaD.D. DimitrovB.D. Impaired nocturnal melatonin in acute phase of ischaemic stroke: Cross-sectional matched case-control analysis.J. Neuroendocrinol.200921765766310.1111/j.1365‑2826.2009.01881.x 19453822
     [Google Scholar]
  9. Adamczak-RatajczakA. KupszJ. OweckiM. ZielonkaD. SowinskaA. Checinska-MaciejewskaZ. Circadian rhythms of melatonin and cortisol in manifest Huntington’s d isease and in acute cortical ischemic stroke.J. Physiol. Pharmacol.2017684539546
     [Google Scholar]
  10. ChernC.M. LiaoJ.F. WangY.H. ShenY.C. Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice.Free Radic. Biol. Med.20125291634164710.1016/j.freeradbiomed.2012.01.030 22330064
     [Google Scholar]
  11. SaccoR.L. KasnerS.E. BroderickJ.P. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke20134472064208910.1161/STR.0b013e318296aeca 23652265
     [Google Scholar]
  12. KwahL.K. DiongJ. National institutes of health stroke scale (NIHSS).J. Physiother.20146016110.1016/j.jphys.2013.12.012 24856948
     [Google Scholar]
  13. AdamsH.P.Jr WoolsonR.F. ClarkeW.R. Design of the trial of Org 10172 in acute stroke treatment (TOAST).Control. Clin. Trials199718435837710.1016/S0197‑2456(97)00012‑3 9257073
     [Google Scholar]
  14. BamfordJ. SandercockP. DennisM. WarlowC. BurnJ. Classification and natural history of clinically identifiable subtypes of cerebral infarction.Lancet199133787561521152610.1016/0140‑6736(91)93206‑O 1675378
     [Google Scholar]
  15. BurtonL. TysonS. Screening for cognitive impairment after stroke: A systematic review of psychometric properties and clinical utility.J. Rehabil. Med.201547319320310.2340/16501977‑1930 25590458
     [Google Scholar]
  16. HamiltonM. A rating scale for depression.J. Neurol. Neurosurg. Psychiatry1960231566210.1136/jnnp.23.1.56 14399272
     [Google Scholar]
  17. HamiltonM. The assessment of anxiety states by rating.Br. J. Med. Psychol.1959321505510.1111/j.2044‑8341.1959.tb00467.x 13638508
     [Google Scholar]
  18. BuysseD.J. ReynoldsC.F.III MonkT.H. BermanS.R. KupferD.J. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research.Psychiatry Res.198928219321310.1016/0165‑1781(89)90047‑4 2748771
     [Google Scholar]
  19. BenloucifS. BurgessH.J. KlermanE.B. Measuring melatonin in humans.J. Clin. Sleep Med.200841666910.5664/jcsm.27083 18350967
     [Google Scholar]
  20. Rzepka-MigutB. PaprockaJ. Melatonin-measurement methods and the factors modifying the results. A systematic review of the literature.Int. J. Environ. Res. Public Health2020176191610.3390/ijerph17061916 32183489
     [Google Scholar]
  21. KasnerS.E. Clinical interpretation and use of stroke scales.Lancet Neurol.20065760361210.1016/S1474‑4422(06)70495‑1 16781990
     [Google Scholar]
  22. RitzenthalerT. NighoghossianN. BerthillerJ. Nocturnal urine melatonin and 6-sulphatoxymelatonin excretion at the acute stage of ischaemic stroke.J. Pineal Res.200946334935210.1111/j.1600‑079X.2009.00670.x 19317798
     [Google Scholar]
  23. RitzenthalerT. LhommeauI. DouillardS. Dynamics of oxidative stress and urinary excretion of melatonin and its metabolites during acute ischemic stroke.Neurosci. Lett.20135441410.1016/j.neulet.2013.02.073 23562888
     [Google Scholar]
  24. PanJ. KonstasA.A. BatemanB. OrtolanoG.A. Pile-SpellmanJ. Reperfusion injury following cerebral ischemia: Pathophysiology, MR imaging, and potential therapies.Neuroradiology20074929310210.1007/s00234‑006‑0183‑z 17177065
     [Google Scholar]
  25. AndrabiS.S. ParvezS. TabassumH. Melatonin and ischemic stroke: Mechanistic roles and action.Adv. Pharmacol. Sci.2015201511110.1155/2015/384750 26435711
     [Google Scholar]
  26. OmarT. Karakayalı M, Yesin M, Alaydın HC, Karabağ Y, Gümüşdağ A. Monocyte to high-density lipoprotein cholesterol ratio is associated w ith the presence of carotid artery disease in acute ischemic stroke.Biomarkers Med.2021157489495
     [Google Scholar]
  27. AslanS DemirAR DemirY Usefulness of plateletcrit in the prediction of major adverse cardiac and cerebrovascular events in patients with carotid artery stenosis.Vascular 20192754798610.1177/170853811984789831027469
     [Google Scholar]
  28. LorenteL. MartínM. Abreu-GonzálezP. Higher serum melatonin levels during the first week of malignant middle cerebral artery infarction in non-surviving patients.Brain Sci.201991234610.3390/brainsci9120346 31795260
     [Google Scholar]
  29. KohP.O. Melatonin regulates the calcium-buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury.J. Pineal Res.201253435836510.1111/j.1600‑079X.2012.01005.x 22639951
     [Google Scholar]
  30. CuzzocreaS. CostantinoG. GittoE. Protective effects of melatonin in ischemic brain injury.J. Pineal Res.200029421722710.1034/j.1600‑0633.2002.290404.x 11068944
     [Google Scholar]
  31. ChitimusD.M. PopescuM.R. VoiculescuS.E. Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease.Biomolecules2020109121110.3390/biom10091211 32825327
     [Google Scholar]
/content/journals/cnr/10.2174/0115672026302380240307091232
Loading
Lower Melatonin Indicates Poor Short-term Prognosis in Patients with Acute Ischemic Stroke
Curr Neurovasc Res 21, 148 (2024); https://doi.org/10.2174/0115672026302380240307091232
/content/journals/cnr/10.2174/0115672026302380240307091232
/content/journals/cnr/10.2174/0115672026302380240307091232
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): acute ischemic stroke; inflammation; melatonin; oxidative stress; prognosis; Stroke

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test